CME Group Inc. (NASDAQ:CME) Shares Sold by InterOcean Capital Group LLC

InterOcean Capital Group LLC lessened its position in CME Group Inc. (NASDAQ:CMEFree Report) by 7.0% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 2,009 shares of the financial services provider’s stock after selling 151 shares during the period. InterOcean Capital Group LLC’s holdings in CME Group were worth $433,000 at the end of the most recent reporting period.

Other large investors have also modified their holdings of the company. Gold Investment Management Ltd. acquired a new stake in shares of CME Group in the 4th quarter worth about $26,000. Salomon & Ludwin LLC acquired a new position in CME Group during the 1st quarter valued at about $28,000. Northwest Financial Advisors acquired a new position in CME Group during the 4th quarter valued at about $28,000. Harbor Investment Advisory LLC increased its stake in CME Group by 966.7% during the 4th quarter. Harbor Investment Advisory LLC now owns 160 shares of the financial services provider’s stock valued at $34,000 after buying an additional 145 shares during the period. Finally, Rise Advisors LLC acquired a new position in CME Group during the 1st quarter valued at about $41,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Trading Up 1.1 %

Shares of CME traded up $2.13 during midday trading on Thursday, hitting $199.38. The stock had a trading volume of 2,080,024 shares, compared to its average volume of 1,968,668. CME Group Inc. has a fifty-two week low of $190.70 and a fifty-two week high of $223.80. The business has a 50-day simple moving average of $200.38 and a two-hundred day simple moving average of $206.98. The firm has a market cap of $71.79 billion, a P/E ratio of 22.68, a price-to-earnings-growth ratio of 6.56 and a beta of 0.52. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 0.10.

CME Group (NASDAQ:CMEGet Free Report) last announced its earnings results on Wednesday, July 24th. The financial services provider reported $2.56 EPS for the quarter, topping the consensus estimate of $2.53 by $0.03. CME Group had a net margin of 56.84% and a return on equity of 12.45%. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.53 billion. During the same period last year, the company posted $2.30 earnings per share. The business’s revenue for the quarter was up 12.7% on a year-over-year basis. As a group, equities analysts forecast that CME Group Inc. will post 9.77 EPS for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, June 25th. Shareholders of record on Friday, June 7th were issued a $1.15 dividend. This represents a $4.60 annualized dividend and a dividend yield of 2.31%. The ex-dividend date of this dividend was Friday, June 7th. CME Group’s payout ratio is 52.33%.

Analyst Ratings Changes

Several equities analysts have commented on CME shares. Keefe, Bruyette & Woods raised their target price on shares of CME Group from $212.00 to $213.00 and gave the company a “market perform” rating in a research note on Thursday. Rosenblatt Securities reissued a “sell” rating and set a $187.00 target price (up previously from $185.00) on shares of CME Group in a research note on Thursday, April 25th. Deutsche Bank Aktiengesellschaft lowered their target price on shares of CME Group from $195.00 to $193.00 and set a “hold” rating on the stock in a research note on Thursday. Piper Sandler lowered their target price on shares of CME Group from $235.00 to $225.00 and set an “overweight” rating on the stock in a research note on Thursday. Finally, JPMorgan Chase & Co. raised their price objective on shares of CME Group from $187.00 to $191.00 and gave the company an “underweight” rating in a research report on Thursday. Three equities research analysts have rated the stock with a sell rating, six have issued a hold rating and three have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $212.64.

Get Our Latest Research Report on CME

Insider Buying and Selling

In related news, Director Terry L. Savage sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The shares were sold at an average price of $210.65, for a total transaction of $526,625.00. Following the completion of the sale, the director now directly owns 17,441 shares in the company, valued at $3,673,946.65. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. In related news, CEO Terrence A. Duffy sold 40,000 shares of the firm’s stock in a transaction that occurred on Monday, April 29th. The shares were sold at an average price of $210.91, for a total transaction of $8,436,400.00. Following the completion of the sale, the chief executive officer now directly owns 67,455 shares in the company, valued at $14,226,934.05. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Terry L. Savage sold 2,500 shares of the firm’s stock in a transaction that occurred on Monday, May 13th. The stock was sold at an average price of $210.65, for a total transaction of $526,625.00. Following the sale, the director now owns 17,441 shares of the company’s stock, valued at $3,673,946.65. The disclosure for this sale can be found here. Over the last three months, insiders sold 54,290 shares of company stock worth $11,393,700. 0.30% of the stock is owned by company insiders.

About CME Group

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Articles

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.